Target intelligence / Profile preview

Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 3 (UBA52P3)

Target
UBA52P3
Molecular classification
Other (processed pseudogene)
01

Overview

UBA52P3 stands for "ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 3" and represents a member of the processed pseudogenes derived from the functional UBA52 gene, which encodes a fusion of ubiquitin and ribosomal protein L40[2][3]. Pseudogenes like UBA52P3 have accumulated mutations (such as nucleotide substitutions and deletions) that disrupt their open reading frames, rendering them incapable of producing a functional protein[2]. The UBA52 pseudogene family in humans includes one functional gene (UBA52) and approximately eight processed pseudogenes[2]. While some pseudogenes can occasionally be transcribed or even translated in atypical scenarios, there is no evidence for UBA52P3 having a functional or therapeutic role, nor is it currently considered a drug target or relevant biomarker[2][3]. Although the functional UBA52 gene is involved in important cellular processes such as protein synthesis and regulation of tumorigenesis and autophagy[1], UBA52P3 is only a pseudogene derivative, not encoding a functional protein. Pseudogenes like UBA52P3 are generally believed to be nonfunctional remnants with no established biological function or disease association[2][3]. Occasionally, expression or translation from pseudogenes has been reported in other genetic contexts, but there is no data suggesting this is relevant for UBA52P3. There is nothing to indicate UBA52P3 itself is considered a therapeutic target, receptor, enzyme, transporter, or has any notable involvement in drug response or human disease. UBA52P3 is a processed pseudogene with no established function, not a druggable target, and is not associated with disease, drugs, or biological pathways. The entry is for a pseudogene, not a functional gene.

Other names
UBA52P3UBA52 pseudogene 3ubiquitin A-52 residue ribosomal protein fusion gene pseudogene 3

Beyond the preview

Go deeper on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 3 (UBA52P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 3 (UBA52P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call